Bezanilla, F. (2008). How membrane proteins sense voltage. Nat. Rev. Mol. Cell
Biol. 9, 323-332. doi:10.1038/nrm2376
Bulman, D. E., Scoggan, K. A., Van Oene, M. D., Nicolle, M. W., Hahn, A. F.,
Tollar, L. L. and Ebers, G. C. (1999). A novel sodium channel mutation in a family
with hypokalemic periodic paralysis. Neurology 53, 1932-1936. doi:10.1212/
WNL.53.9.1932
Campos, F. V., Chanda, B., Roux, B. and Bezanilla, F. (2007). Two atomic
constraints unambiguously position the S4 segment relative to S1 and S2
segments in the closed state of Shaker K channel. Proc. Natl. Acad. Sci. USA 104,
7904-7909. doi:10.1073/pnas.0702638104
Cannon, S. C. (2010). Voltage-sensor mutations in channelopathies of skeletal
muscle. J. Physiol. 588, 1887-1895. doi:10.1113/jphysiol.2010.186874
Cannon, S. C. (2015). Channelopathies of skeletal muscle excitability.
Comprehens. Physiol. 5, 761-790. doi:10.1002/cphy.c140062
Capes, D. L., Arcisio-Miranda, M., Jarecki, B. W., French, R. J. and Chanda, B.
(2012). Gating transitions in the selectivity filter region of a sodium channel are
coupled to the domain IV voltage sensor. Proc. Natl. Acad. Sci. USA 109,
2648-2653. doi:10.1073/pnas.1115575109
DiFranco, M., Yu, C., Quinonez,
M. and Vergara, J. L. (2015). Inward rectifier
potassium currents in mammalian skeletal muscle. J. Physiol. 593, 1213-1238.
doi:10.1113/jphysiol.2014.283648
Friend, K. L., Crimmins, D., Phan, T. G., Sue, C. M., Colley, A., Fung, V. S. C.,
Morris, J. G. L., Sutherland, G. R. and Richards, R. I. (1999). Detection of a
novel missense mutation and second recurrent mutation in the CACNA1A gene in
individuals with EA-2 and FHM. Hum. Genet. 105, 261-265. doi:10.1007/
s004399900101
Gamal El-Din, T. M., Lantin, T., Tschumi, C. W., Juarez, B., Quinlan, M.,
Hayano, J. H., Li, J., Zweifel, L. S. and Catterall, W. A. (2021). Autismassociated mutations in KV7 channels induce gating pore current. Proc. Natl.
Acad. Sci. USA 118, e2112666118. doi:10.1073/pnas.2112666118
Disease Models & Mechanisms
Proton transport assay
Disease Models & Mechanisms (2023) 16, dmm049704. doi:10.1242/dmm.049704
Gosselin-Badaroudine, P., Delemotte, L., Moreau, A., Klein, M. L. and
Chahine, M. (2012a). Gating pore currents and the resting state of Nav1.4
voltage sensor domains. Proc. Natl Acad. Sci. USA 109, 19250-19255. doi:10.
1073/pnas.1217990109
Gosselin-Badaroudine, P., Keller, D. I., Huang, H., Pouliot, V., Chatelier, A.,
Osswald, S., Brink, M. and Chahine, M. (2012b). A proton leak current through
the cardiac sodium channel is linked to mixed arrhythmia and the dilated
cardiomyopathy phenotype. PLoS ONE 7, e38331. doi:10.1371/journal.pone.
0038331
Groome, J. R., Lehmann-Horn, F., Fan, C., Wolf, M., Winston, V., Merlini, L. and
Jurkat-Rott, K. (2014). NaV1.4 mutations cause hypokalaemic periodic paralysis
by disrupting IIIS4 movement during recovery. Brain 137, 998-1008. doi:10.1093/
brain/awu015
Jehasse, K., Massotte, L., Hartmann, S., Vitello, R., Ringlet, S., Vitello, M.,
Chua, H. C., Pless, S. A., Engel, D., Lié geois, J.-F. et al. (2021). The gating pore
blocker 1-(2,4-xylyl)guanidinium selectively inhibits pacemaking of midbrain
dopaminergic neurons. Neuropharmacology 197, 108722. doi:10.1016/J.
NEUROPHARM.2021.108722
Jitpimolmard, N., Matthews, E. and Fialho, D. (2020). Treatment updates for
neuromuscular channelopathies. Curr. Treatment Opt. Neurol. 22, 34. doi:10.
1007/s11940-020-00644-2
Jurkat-Rott, K., Mitrovic, N., Hang, C., Kouzmenkine, A., Iaizzo, P., Herzog, J.,
Lerche, H., Nicole, S., Vale-Santos, J., Chauveau, D. et al. (2000). Voltagesensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by
enhanced inactivation and reduced current. Proc. Natl Acad. Sci. USA 97,
9549-9554. doi:10.1073/pnas.97.17.9549
Kirkton, R. D. and Bursac, N. (2011). Engineering biosynthetic excitable tissues
from unexcitable cells for electrophysiological and cell therapy studies. Nat.
Commun. 2, 300. doi:10.1038/NCOMMS1302
Kowarz, E., Lö scher, D. and Marschalek, R. (2015). Optimized Sleeping Beauty
transposons rapidly generate stable transgenic cell lines. Biotechnol. J. 10,
647-653. doi:10.1002/biot.201400821
Lacroix, J. J., Clark Hyde, H., Campos, F. V. and Bezanilla, F. (2014). Moving
gating charges through the gating pore in a Kv channel voltage sensor. Proc. Natl.
Acad. Sci. USA 111, E1950-E1959. doi:10.1073/pnas.1406161111
Leisgen, C., Kuester, M. and Methfessel, C. (2007). The roboocyte: automated
electrophysiology based on Xenopus oocytes. Methods Mol. Biol. 403, 87-109.
doi:10.1007/978-1-59745-529-9_6
Li, Q., Wanderling, S., Paduch, M., Medovoy, D., Singharoy, A., Mcgreevy, R.,
Villalba-Galea, C. A., Hulse, R. E., Roux, B., Schulten, K. et al. (2014).
Structural mechanism of voltage-dependent gating in an isolated voltage-sensing
domain. Nat. Struct. Mol. Biol. 21, 244-252. doi:10.1038/nsmb.2768
Mä nnikkö , R., Shenkarev, Z. O., Thor, M. G., Berkut, A. A., Myshkin, M. Y.,
Paramonov, A. S., Kulbatskii, D. S., Kuzmin, D. A., Castañeda, M. S., King, L.
et al. (2018). Spider toxin inhibits gating pore currents underlying periodic
paralysis. Proc. Natl. Acad. Sci. USA 115, 4495-4500. doi:10.1073/pnas.
1720185115
Matthews, E., Labrum, R., Sweeney, M. G., Sud, R., Haworth, A., Chinnery, P. F.,
Meola, G., Schorge, S., Kullmann, D. M., Davis, M. B. et al. (2009). Voltage
sensor charge loss accounts for most cases of hypokalemic periodic paralysis.
Neurology 72, 1544-1547. doi:10.1212/01.wnl.0000342387.65477.46
Matthews, E., Portaro, S., Ke, Q., Sud, R., Haworth, A., Davis, M. B.,
Griggs, R. C. and Hanna, M. G. (2011). Acetazolamide efficacy in
hypokalemic periodic paralysis and the predictive role of genotype. Neurology
77, 1960-1964. doi:10.1212/WNL.0b013e31823a0cb6
Moreau, A., Gosselin-Badaroudine, P., Boutjdir, M. and Chahine, M. (2015a).
Mutations in the voltage sensors of domains I and II of Nav1.5 that are associated
with arrhythmias and dilated cardiomyopathy generate gating pore currents. Front.
Pharmacol. 6, 301. doi:10.3389/FPHAR.2015.00301
Moreau, A., Gosselin-Badaroudine, P., Delemotte, L., Klein, M. L. and
Chahine, M. (2015b). Gating pore currents are defects in common with two
Nav1.5 mutations in patients with mixed arrhythmias and dilated cardiomyopathy.
J. Gen. Physiol. 145, 93-106. doi:10.1085/jgp.201411304
Moreau, A., Gosselin-Badaroudine, P., Mercier, A., Burger, B., Keller, D. I. and
Chahine, M. (2018). A leaky voltage sensor domain of cardiac sodium channels
causes arrhythmias associated with dilated cardiomyopathy. Sci. Rep. 8, 13804.
doi:10.1038/S41598-018-31772-0
Nguyen, H. X., Kirkton, R. D. and Bursac, N. (2016). Engineering prokaryotic
channels for control of mammalian tissue excitability. Nat. Commun. 7, 13132.
doi:10.1038/NCOMMS13132
Pan, X., Li, Z., Zhou, Q., Shen, H., Wu, K., Huang, X., Chen, J., Zhang, J., Zhu, X.,
Lei, J. et al. (2018). Structure of the human voltage-gated sodium channel Nav1.4
in complex with β1. Science 362, eaau2486. doi:10.1126/science.aau2486
Perni, S., Lavorato, M. and Beam, K. G. (2017). De novo reconstitution reveals the
proteins required for skeletal muscle voltage-induced Ca2+ release. Proc. Natl.
Acad. Sci. USA 114, 13822-13827. doi:10.1073/pnas.1716461115
Rouillard, A. D., Gundersen, G. W., Fernandez, N. F., Wang, Z., Monteiro, C. D.,
McDermott, M. G. and Ma’ayan, A. (2016). The harmonizome: a collection of
processed datasets gathered to serve and mine knowledge about genes and
proteins. Database 2016, baw100. doi:10.1093/database/baw100
Rü del, R., Lehmann-Horn, F., Ricker, K. and Kü ther, G. (1984). Hypokalemic
periodic paralysis: In vitro investigation of muscle fiber membrane parameters.
Muscle Nerve 7, 110-120. doi:10.1002/mus.880070205
Sansone, V. A., Burge, J., Mcdermott, M. P., Smith, P. C., Herr, B., Tawil, R.,
Pandya, S., Kissel, J., Ciafaloni, E., Shieh, P. et al. (2016). Randomized,
placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology 86,
1408-1416. doi:10.1212/WNL.0000000000002416
Sansone, V. A., Johnson, N. E., Hanna, M. G., Ciafaloni, E., Statland, J. M.,
Shieh, P. B., Cohen, F. and Griggs, R. C. (2021). Long-term efficacy and safety
of dichlorphenamide for treatment of primary periodic paralysis. Muscle Nerve 64,
342-346. doi:10.1002/mus.27354
Sasaki, R., Nakaza, M., Furuta, M., Fujino, H., Kubota, T. and
Takahashi, M. P. (2020). Mutation spectrum and health status in skeletal
muscle channelopathies in Japan. Neuromuscul. Disord. 30, 546-553. doi:10.
1016/j.nmd.2020.06.001
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M.,
Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B. et al.
(2012). Fiji: An open-source platform for biological-image analysis. Nat. Methods
9, 676-682. doi:10.1038/nmeth.2019
Schlief, T., Schö nherr, R., Imoto, K. and Heinemann, S. H. (1996). Pore
properties of rat brain II sodium channels mutated in the selectivity filter domain.
Eur. Biophys. J. 25, 75-91. doi:10.1007/s002490050020
Sokolov, S., Scheuer, T. and Catterall, W. A. (2007). Gating pore current in an
inherited ion channelopathy. Nature 446, 76-78. doi:10.1038/nature05598
Sokolov, S., Scheuer, T. and Catterall, W. A. (2008). Depolarization-activated
gating pore current conducted by mutant sodium channels in potassium-sensitive
normokalemic periodic paralysis. Proc. Natl. Acad. Sci. USA 105, 19980-19985.
doi:10.1073/pnas.0810562105
Sokolov, S., Scheuer, T. and Catterall, W. A. (2010). Ion permeation and block of
the gating pore in the voltage sensor of NaV1.4 channels with hypokalemic
periodic paralysis mutations. J. Gen. Physiol. 136, 225-236. doi:10.1085/jgp.
201010414
Starace, D. M. and Bezanilla, F. (2004). A proton pore in a potassium channel
voltage sensor reveals a focused electric field. Nature 427, 548-553. doi:10.1038/
nature02270
Statland, J. M., Fontaine, B., Hanna, M. G., Johnson, N. E., Kissel, J. T.,
Sansone, V. A., Shieh, P. B., Tawil, R. N., Trivedi, J., Cannon, S. C. et al.
(2018). Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve
57, 522-530. doi:10.1002/mus.26009
Stefani, E. and Bezanilla, F. (1998). [17] Cut-open oocyte voltage-clamp technique.
Methods Enzymol. 293, 300-318. doi:10.1016/S0076-6879(98)93020-8
Struyk, A. F. and Cannon, S. C. (2007). A Na+ channel mutation linked to
hypokalemic periodic paralysis exposes a proton-selective gating pore. J. Gen.
Physiol. 130, 11-20. doi:10.1085/jgp.200709755
Struyk, A. F., Markin, V. S., Francis, D. and Cannon, S. C. (2008). Gating pore
currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis:
saturation of ion flux and implications for disease pathogenesis. J. Gen.
Physiol. 132, 447-464. doi:10.1085/jgp.200809967
Tantsis, E. M., Gill, D., Griffiths, L., Gupta, S., Lawson, J., Maksemous, N.,
Ouvrier, R., Riant, F., Smith, R., Troedson, C. et al. (2016). Eye movement
disorders are an early manifestation of CACNA1A mutations in children. Dev.
Med. Child Neurol. 58, 639-644. doi:10.1111/dmcn.13033
Tao, X., Lee, A., Limapichat, W., Dougherty, D. A. and Mackinnon, R. (2010).
A gating charge transfer center in voltage sensors. Science 328, 67-73. doi:10.
1126/science.1185954
Torres, C. F., Griggs, R. C., Moxley, R. T. and Bender, A. N. (1981). Hypokalemic
periodic paralysis exacerbated by acetazolamide. Neurology 31, 1423-1428.
doi:10.1212/WNL.31.11.1423
Villalba-Galea, C. A., Sandtner, W., Starace, D. M. and Bezanilla, F. (2008). S4based voltage sensors have three major conformations. Proc. Natl. Acad. Sci.
USA 105, 17600-17607. doi:10.1073/pnas.0807387105
Wasano, K., Takahashi, S., Rosenberg, S. K., Kojima, T., Mutai, H.,
Matsunaga, T., Ogawa, K. and Homma, K. (2020). Systematic quantification
of the anion transport function of pendrin (SLC26A4) and its disease-associated
variants. Hum. Mutat. 41, 316-331. doi:10.1002/humu.23930
Wu, F., Mi, W., Burns, D. K., Fu, Y., Gray, H. F., Struyk, A. F. and Cannon, S. C.
(2011). A sodium channel knockin mutant (NaV1.4-R669H) mouse model of
hypokalemic periodic paralysis. J. Clin. Investig. 121, 4082-4094. doi:10.1172/
JCI57398
Wu, F., Mi, W., Herná ndez-Ochoa, E. O., Burns, D. K., Fu, Y., Gray, H. F.,
Struyk, A. F., Schneider, M. F. and Cannon, S. C. (2012). A calcium channel
mutant mouse model of hypokalemic periodic paralysis. J. Clin. Investig. 122,
4580-4591. doi:10.1172/JCI66091
Wu, F., Mi, W. and Cannon, S. C. (2013a). Bumetanide prevents transient
decreases in muscle force in murine hypokalemic periodic paralysis. Neurology
80, 1110-1116. doi:10.1212/WNL.0b013e3182886a0e
Wu, F., Mi, W. and Cannon, S. C. (2013b). Beneficial effects of bumetanide in a
CaV1.1-R528H mouse model of hypokalaemic periodic paralysis. Brain 136,
3766-3774. doi:10.1093/brain/awt280
10
Disease Models & Mechanisms
RESOURCE ARTICLE
Disease Models & Mechanisms (2023) 16, dmm049704. doi:10.1242/dmm.049704
Yoon, J. S., Park, H.-J., Yoo, S.-Y., Namkung, W., Jo, M. J., Koo, S. K., Park, H.Y., Lee, W.-S., Kim, K. H. and Lee, M. G. (2008). Heterogeneity in the processing
defect of SLC26A4 mutants. J. Med. Genet. 45, 411-419. doi:10.1136/jmg.2007.
054635
Zaharieva, I. T., Thor, M. G., Oates, E. C., Van Karnebeek, C., Hendson, G.,
Blom, E., Witting, N., Rasmussen, M., Gabbett, M. T., Ravenscroft, G. et al.
(2016). Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or
‘classical’ congenital myopathy. Brain 139, 674-691. doi:10.1093/brain/awv352
Disease Models & Mechanisms
RESOURCE ARTICLE
11
...